Breaking News: Local health officials report one confirmed case of mumps; five others under investigation

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

EDINBURG – Local health authorities report one confirmed case of the mumps and five possible mumps cases that are under investigation.

Mumps is a contagious virus that causes fever, muscle aches, headache, loss of appetite, and swelling of the salivary glands, which can include the jaw and neck area. Other glands can swell or become tender, most notably adult males may experience swollen or tender testicles.

The confirmed case is a University of Texas Rio Grande Valley student, but it is believed that the source of the virus is not the university, said Hidalgo County Health and Human Services Director Eduardo “Eddie” Olivarez.

- Advertisement -

Olivarez also confirmed that the illness was not generated by the county’s immigrant community.

Area physicians and health care workers have been alerted to test for mumps in patients showing symptoms. Complications or other presentations are rare and usually mild.

People who are vaccinated may still contract the mumps but will have milder symptoms. Mumps is a preventable illness when the population is vaccinated, said Olivarez.

If you suspect you have the mumps, you are encouraged to be tested by your physician. People who are not vaccinated should get the vaccine.

- Advertisement -

“If you are unsure of your vaccination status, please see your physician for evaluation,” said Olivarez.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Cybersecurity Alert as Hackers Exploit Computer and Smartphone Vulnerabilities

Federal cybersecurity authorities are urging computer and smartphone users to keep their devices updated following reports of actively exploited security vulnerabilities affecting Apple products and Google’s Chrome browse

American Cancer Society Updates Prostate Cancer Screening Guideline

The American Cancer Society (ACS) released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease.

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 
- Advertisement -